Momeson Nasal Spray

Indications

Momeson nasal spray is specifically designed for individuals aged 2 years and older to address the nasal symptoms associated with allergic rhinitis. It effectively alleviates nasal congestion linked to seasonal allergic rhinitis for patients aged 2 years and older. For patients aged 12 years and above, it serves as a preventive measure against seasonal allergic rhinitis. Additionally, it is indicated for the treatment of nasal polyps in adults aged 18 years and older.

Always consult a registered healthcare professional before using this medication.

Pharmacology

Mometasone Furoate is a corticosteroid recognized for its anti-inflammatory properties. While the exact mechanism by which corticosteroids affect allergic rhinitis remains unclear, they exhibit diverse effects on various immune cells (including mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators (such as histamine, eicosanoids, leukotrienes, and cytokines) that play pivotal roles in inflammation.

Dosage

Allergic Rhinitis:

• Adults and Children (12 years and older): The recommended dosage for both prophylaxis and treatment of nasal symptoms from seasonal and perennial allergic rhinitis is two sprays (50 mcg of Mometasone Furoate per spray) in each nostril once daily, totaling 100 mcg. For individuals with a known seasonal allergen that triggers nasal symptoms, it’s advisable to start prophylaxis with Mometasone Nasal Spray (50 mcg) at a dosage of 200 mcg per day for 2 to 4 weeks before the anticipated pollen season begins.
• Children (2 to 11 years): For managing nasal symptoms from seasonal and perennial allergic rhinitis, the recommended dose is one spray (50 mcg of Mometasone Furoate per spray) in each nostril once daily, totaling 100 mcg.

Nasal Polyps:

• Adults (18 years and older): For the treatment of nasal polyps, the suggested dosage is two sprays (50 mcg per spray) in each nostril twice daily, resulting in a total daily dose of 400 mcg. In some cases, a dosage of two sprays in each nostril once daily (totaling 200 mcg) may also be effective.

Always consult a registered healthcare professional before using this medication.

Administration

Instructions for Using the Nasal Spray:

1. Gently shake the bottle and remove the dust cover.
2. Hold the spray with your forefinger and middle finger on either side of the nozzle and your thumb underneath. Press down until a fine mist appears. If this is your first time using it or if it hasn’t been used for a week or more, pump the applicator several times until a fine mist is released.
3. Gently blow your nose to clear your nostrils.
4. Close one nostril and insert the nasal applicator into the open nostril. Tilt your head forward slightly, keeping the spray upright. Breathe in through your nose while firmly pressing down on the nasal applicator to release a spray.
5. Exhale through your mouth.
6. Repeat the steps in the same or opposite nostril for additional doses.

Cleaning Instructions: To maintain hygiene, clean the nasal spray at least once a week:

1. Remove the dust cover.
2. Gently detach the nasal applicator.
3. Wash the applicator and dust cover in warm water.
4. Shake off excess water and allow them to dry naturally; avoid applying heat.
5. Reattach the applicator to the bottle and replace the dust cover.

Always consult a registered healthcare professional before using this medication.

Interaction

No significant drug interactions have been reported with Momeson.

Contraindications

Momeson should not be used in individuals with hypersensitivity to any of its components.

Side Effects

Typically mild side effects may include headaches, viral infections, pharyngitis, epistaxis (nosebleeds), and coughing.

Pregnancy & Lactation

Pregnancy Category C: Adequate and well-controlled studies in pregnant women are lacking. Mometasone Furoate, like other corticosteroids, should be administered during pregnancy only if the potential benefits outweigh the risks to the fetus. It remains unknown whether Mometasone Furoate is excreted in human milk. Given that other corticosteroids do pass into breast milk, caution is advised when administering Mometasone Furoate Nasal Spray to nursing mothers.

Precautions & Warnings

Exercise caution when prescribing nasal corticosteroids to patients with active or latent tuberculosis, untreated fungal, bacterial, or systemic viral infections, or ocular herpes simplex. Regularly monitor patients for any signs of adverse effects on the nasal mucosa. Avoid use in individuals with recent nasal ulcers, nasal surgery, or nasal trauma. Patients with changes in vision or a history of increased intraocular pressure, glaucoma, or cataracts should be monitored closely.

Use in Special Populations

Pediatric Use: The safety and efficacy of Momeson Nasal Spray in children under 2 years of age have not been established.

Therapeutic Class

Nasal Steroid Preparations

Storage Conditions

Store the product at temperatures not exceeding 30°C. Protect from light and moisture. Keep out of reach of children.